Krystal Biotech, Inc. (KRYS) NASDAQ

251.29

-2.07(-0.82%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap4.48B
Enterprise Value4.14B
P/E Ratio36.58
PEG Ratio1.04
Price/Sales Ratio19.53
Price/Book Ratio6.39
Enterprise/Revenue18.48
Enterprise/EBITDA40.46

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.53
Operating Margin0.42

Management Effectiveness

Return On Assets0.16
Return On Equity0.19

Income Statement

Revenue290.52M
Revenue/Share12.89
Gross Profit270.45M
EBITDA109.91M
Net Income89.16M
Diluted EPS3

Balance Sheet

Total Cash731.07M
Total Cash/Share25.25
Total Debt9.51M
Total Debt/Equity0
Current Ratio10.14
Book Value Per Share39.3

Price History

52-Week Change58.52
52-Week High255
52-Week Low122.8
Moving Average 50 Days211.37
Moving Average 200 Days168.43

Statistics

Average Volume308,704
Shares Outstanding29M
% Held by Institutions96.88

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A